Weiner, David B.

DNA vaccines: ready for prime time?

Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics

Immunotherapy and Immune ResponsesRNA Interference and Gene Delivery

Cited by 1,077

Immunogenicity of a DNA vaccine candidate for COVID-19

Smith, T. R. F., Patel, A., Ramos, S., Elwood, D., Zhu, X., Yan, J., Gary, E. N., Walker, S. N., Schultheis, K., Purwar, M., et al. (2020) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 601

Electroporation delivery of DNA vaccines: prospects for success

Sardesai, N. Y., & Weiner, D. B. (2011) · Current Opinion in Immunology

Microbial Inactivation MethodsImmunotherapy and Immune Responses

Cited by 416

DNA vaccines: prime time is now

Gary, E. N., & Weiner, D. B. (2020) · Current Opinion in Immunology

Immunotherapy and Immune ResponsesRNA Interference and Gene Delivery

Cited by 190

Deep Mining of the Human Antibody Repertoire Identifies Frequent and Genetically Diverse CDRH3 Topologies Targetable by Vaccination

Habib, R., Solieva, S. O., Lin, Z. J., Ghosh, S., Bayruns, K., Singh, M., Agostino, C. J., Tursi, N. J., Sowers, K. J., Huang, J., et al. (2024) · Proceedings of the National Academy of Sciences

HIV Research and TreatmentMonoclonal and Polyclonal Antibodies Research

Cited by 8

Conformational landscape of HIV-1 Env from closed to fully open

Cui, J., Lin, Z. J., Ghosh, S., Du, J., Sadeesh, R., Weiner, D. B., & Pallesen, J. (2026) · Nature Communications

HIV Research and TreatmentAdvanced Electron Microscopy Techniques and Applications

Cited by 1